These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28631159)

  • 21. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.
    Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P
    Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report.
    Del Gobbo A; Fusco N; Barella M; Ercoli G; Sciarra A; Palleschi A; Pagni F; Marchiò C; Papotti M; Ferrero S
    Cell Oncol (Dordr); 2018 Dec; 41(6):687-691. PubMed ID: 30182340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological Profiling of Lung Carcinoids with a Ki67 Index > 20.
    Kasajima A; Konukiewitz B; Oka N; Suzuki H; Sakurada A; Okada Y; Kameya T; Ishikawa Y; Sasano H; Weichert W; Klöppel G
    Neuroendocrinology; 2019; 108(2):109-120. PubMed ID: 30485860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Typical and atypical pulmonary carcinoids--pathologic and clinical analysis of 77 cases].
    Słodkowska J; Langfort R; Rudziński P; Kupis W
    Pneumonol Alergol Pol; 1998; 66(5-6):297-303. PubMed ID: 9857650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential diagnostic patterns of lung neuroendocrine tumours. A clinico-pathological and immunohistochemical study of 122 cases.
    Bonato M; Cerati M; Pagani A; Papotti M; Bosi F; Bussolati G; Capella C
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(3):201-11. PubMed ID: 1372778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptomic data helps refining classification of pulmonary carcinoid tumors with increased mitotic counts.
    Sazonova O; Manem V; Orain M; Khoshkrood-Mansoori B; Gaudreault N; Desmeules P; Bossé Y; Joubert P
    Mod Pathol; 2020 Sep; 33(9):1712-1721. PubMed ID: 32291397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.
    Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A
    Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Grading the neuroendocrine tumors of the lung: an evidence-based proposal.
    Rindi G; Klersy C; Inzani F; Fellegara G; Ampollini L; Ardizzoni A; Campanini N; Carbognani P; De Pas TM; Galetta D; Granone PL; Righi L; Rusca M; Spaggiari L; Tiseo M; Viale G; Volante M; Papotti M; Pelosi G
    Endocr Relat Cancer; 2014 Feb; 21(1):1-16. PubMed ID: 24344249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathological features and prognosis of different gastric carcinoid subtypes].
    Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
    Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
    J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Retrospective study of clinicopathological characteristics in bronchopulmonary carcinoid].
    Liao H; Rao H; Zhang X; Lin Y; Jie M; Fu J; Long H; Rong T; Lin P
    Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):591-7. PubMed ID: 20681445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer.
    Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Nishimaki H; Masuda S
    Radiat Oncol; 2017 Jan; 12(1):16. PubMed ID: 28086989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
    Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
    Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
    Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
    J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.
    Kaemmerer D; Reimann C; Specht E; Wirtz RM; Sayeg M; Baum RP; Schulz S; Lupp A
    Oncotarget; 2015 Feb; 6(5):3346-58. PubMed ID: 25671300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proliferative activity in pulmonary carcinoids].
    Resl M; Bukac J; Simek J; Siller J; Rothröckel P
    Cesk Patol; 2000 Jan; 36(1):32-4. PubMed ID: 10838756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External Validation of a Prognostic Model of Survival for Resected Typical Bronchial Carcinoids.
    Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
    Ann Thorac Surg; 2017 Oct; 104(4):1215-1220. PubMed ID: 28821334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are goblet cell carcinoids a group of heterogeneous tumors?
    Macak J; Nemejcova K; Dvorackova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):281-285. PubMed ID: 28659644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.